Circulation, Vol 84, 1118-1129, Copyright © 1991 by American Heart Association
HP Schobel, RM Oren, PJ Roach, AL Mark and DW Ferguson
BACKGROUND. Digitalis glycosides augment cardiopulmonary baroreceptor
mechanisms in animals. This could result from inotropic actions or from
direct sensitization of cardiac mechanoreceptors. METHODS AND RESULTS. To
determine if digitalis has similar actions in humans and to evaluate the
mechanisms involved, we measured muscle sympathetic nerve activity (MSNA;
microneurography) during unloading of cardiopulmonary baroreceptors with
incremental lower body negative pressure (LBNP; 0 to -15 mm Hg) and during
the cold pressor test in 22 normal subjects (age 22 +/- 1 year, mean +/-
SEM). Arterial and central venous pressures, heart rate, and MSNA were
measured during LBNP before and after intravenous digitalis (Cedilanid 0.02
ng/kg, n = 8), dobutamine (2.8 +/- 0.5 micrograms/kg/min, n = 8), or
placebo (n = 6). Digitalis and dobutamine produced similar increases in
baseline mean arterial pressure and decreases in central venous pressure
and MSNA. LBNP produced similar decreases in central venous pressure in all
groups before and after drug administration. The MSNA responses to LBNP
were markedly potentiated by digitalis but not by dobutamine or placebo.
CONCLUSIONS. Digitalis did not alter responses to the cold pressor test.
Thus, digitalis selectively potentiated cardiopulmonary baroreflex
regulation of sympathetic neural responses in normal humans, whereas
dobutamine (another positive inotropic agent) did not produce this effect.
We conclude that digitalis augments cardiopulmonary baroreflex control of
sympathetic activity, probably by direct baroreceptor sensitization.
ARTICLES
Contrasting effects of digitalis and dobutamine on baroreflex sympathetic control in normal humans
Clinical Cardiovascular Physiology Laboratory, University of Iowa Hospitals, Iowa City 52242.
This article has been cited by other articles:
![]() |
S. Velez-Roa, M. Renard, J.-P. Degaute, and P. van de Borne Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1605 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Al-Hesayen, E. R. Azevedo, G. E. Newton, and J. D. Parker The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure J. Am. Coll. Cardiol., April 17, 2002; 39(8): 1269 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Schobel, H. Frank, R. Naraghi, H. Geiger, E. Titz, and K. Heusser Hypertension in Patients with Neurovascular Compression Is Associated with Increased Central Sympathetic Outflow J. Am. Soc. Nephrol., January 1, 2002; 13(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Grassi, D. Spaziani, G. Seravalle, G. Bertinieri, R. Dell'Oro, C. Cuspidi, and G. Mancia Effects of Amlodipine on Sympathetic Nerve Traffic and Baroreflex Control of Circulation in Heart Failure Hypertension, February 1, 1999; 33(2): 671 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Schobel, R. E. Schmieder, S. Hartmann, H. Schachinger, and F. C. Luft Effects of Bromocriptine on Cardiovascular Regulation in Healthy Humans Hypertension, May 1, 1995; 25(5): 1075 - 1082. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |